DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer

Gastric cancer (GC) is a very common malignancy with a poor prognosis, and its occurrence and development are closely related to epigenetic modifications. Methylation of DNA before or during gastric cancer is an interesting research topic. This article reviews the studies on DNA methylation related...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yunqing, Rong, Huimin, Xu, Jianwei, Cao, Ruyue, Li, Shuhua, Gao, Yanjing, Cheng, Baoquan, Zhou, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931997/
https://www.ncbi.nlm.nih.gov/pubmed/35309131
http://dx.doi.org/10.3389/fgene.2022.823905
Descripción
Sumario:Gastric cancer (GC) is a very common malignancy with a poor prognosis, and its occurrence and development are closely related to epigenetic modifications. Methylation of DNA before or during gastric cancer is an interesting research topic. This article reviews the studies on DNA methylation related to the cause, diagnosis, treatment, and prognosis of gastric cancer and aims to find cancer biomarkers to solve major human health problems.

Ejemplares similares